Mode of Action Frameworks: A Critical Analysis

Mode of action (MOA) information is increasingly being applied in human health risk assessment. The MOA can inform issues such as the relevance of observed effects in laboratory animals to humans, and the variability of response within the human population. Several collaborative groups have developed frameworks for analyzing and utilizing MOA information in human health risk assessment of environmental carcinogens and toxins, including the International Programme on Chemical Safety, International Life Sciences Institute, and U.S. Environmental Protection Agency. With the goal of identifying gaps and opportunities for progress, we critically evaluate several of these MOA frameworks. Despite continued improvement in incorporating biological data in human health risk assessment, several notable challenges remain. These include articulation of the significant role of scientific judgment in establishing an MOA and its relevance to humans. In addition, binary (yes/no) decisions can inappropriately exclude consideration of data that may nonetheless be informative to the overall assessment of risk. Indeed, the frameworks lack a broad consideration of known causes of human disease and the potential for chemical effects to act additively with these as well as endogenous background processes. No integrated analysis of the impact of multiple MOAs over the same dose range, or of varying MOAs at different life stages, is included. Separate consideration of each MOA and outcome limits understanding of how multiple metabolites, modes, and toxicity pathways contribute to the toxicological profile of the chemical. An extension of the analyses across outcomes with common modes is also needed.

[1]  Robert Kavlock,et al.  Mode of Action: Reduction of Testosterone Availability—Molinate-Induced Inhibition of Spermatogenesis , 2005, Critical reviews in toxicology.

[2]  U. Epa Guidelines for carcinogen risk assessment , 1986 .

[3]  H J Clewell,et al.  Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[4]  M L Dourson,et al.  Applications of mechanistic data in risk assessment: the past, present, and future. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Melvin E. Andersen,et al.  Applying Mode-of-Action and Pharmacokinetic Considerations in Contemporary Cancer Risk Assessments: An Example with Trichloroethylene , 2004 .

[6]  W. Kobel,et al.  Health risk of low-dose pesticides mixtures: a review of the 1985-1998 literature on combination toxicology and health risk assessment. , 2000, Journal of toxicology and environmental health. Part B, Critical reviews.

[7]  L. McCarty,et al.  Can mode of action predict mixture toxicity for risk assessment? , 2004, Toxicology and applied pharmacology.

[8]  J I Goodman,et al.  A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors. , 1994, Regulatory toxicology and pharmacology : RTP.

[9]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[10]  J. Groten,et al.  Toxicological evaluation and risk assessment of chemical mixtures. , 1998, Critical reviews in toxicology.

[11]  R B Conolly,et al.  Cancer and non-cancer risk assessment: not so different if you consider mechanisms. , 1995, Toxicology.

[12]  W. Lutz,et al.  Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. , 1998, Mutation research.

[13]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[14]  J. Goodman A Perspective on Current and Future Uses of Alternative Models for Carcinogenicity Testing , 2001, Toxicologic pathology.

[15]  Michael Höfler,et al.  Getting causal considerations back on the right track , 2006, Emerging themes in epidemiology.

[16]  G. Diggle,et al.  Science and Judgement in Risk Assessment , 1995 .

[17]  Gary L Ginsberg,et al.  Assessing Cancer Risks from Short‐Term Exposures in Children , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[18]  Vicki L Dellarco,et al.  A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[20]  Lau Caspar Thygesen,et al.  A philosophical analysis of the Hill criteria , 2005, Journal of Epidemiology and Community Health.

[21]  Edward D Levin,et al.  Mode of Action: Disruption of Brain Cell Replication, Second Messenger, and Neurotransmitter Systems During Development Leading to Cognitive Dysfunction—Developmental Neurotoxicity of Nicotine , 2005, Critical reviews in toxicology.

[22]  C. Kimmel,et al.  Developmental stage sensitivity and mode of action information for androgen agonists and antagonists. , 2001, The Science of the total environment.

[23]  S. Greenland,et al.  Causation and causal inference in epidemiology. , 2005, American journal of public health.

[24]  Vicki L Dellarco,et al.  Mode of action in relevance of rodent liver tumors to human cancer risk. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  Jennifer Seed,et al.  Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.

[26]  S. Tabacova,et al.  Mode of Action: Angiotensin-Converting Enzyme Inhibition—Developmental Effects Associated With Exposure to ACE Inhibitors , 2005, Critical reviews in toxicology.

[27]  Kevin M Crofton,et al.  Mode of Action: Neurotoxicity Induced by Thyroid Hormone Disruption During Development—Hearing Loss Resulting From Exposure to PHAHs , 2005, Critical reviews in toxicology.

[28]  P. Foster Mode of Action: Impaired Fetal Leydig Cell Function—Effects on Male Reproductive Development Produced by Certain Phthalate Esters , 2005, Critical reviews in toxicology.

[29]  M E Andersen,et al.  Mode of action and tissue dosimetry in current and future risk assessments. , 2001, The Science of the total environment.

[30]  Paolo Vineis,et al.  Causal models in epidemiology: past inheritance and genetic future , 2006, Environmental health : a global access science source.

[31]  Jeanette Wiltse,et al.  Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin—Developmental Effects of Valproic Acid , 2005, Critical reviews in toxicology.

[32]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[33]  Michael S Victoroff,et al.  Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.

[34]  Michael Dourson,et al.  Data considerations for regulation of water contaminants. , 2006, Toxicology.

[35]  W. H. Farland,et al.  Workshop report on EPA (Environmental Protection Agency) guidelines for carcinogen risk assessment. Held in Virginia Beach, Virginia on January 11-13, 1989 , 1989 .

[36]  P. Hoyer,et al.  Reproductive toxicology: current and future directions. , 2001, Biochemical pharmacology.

[37]  E M Faustman,et al.  A systems-based computational model for dose-response comparisons of two mode of action hypotheses for ethanol-induced neurodevelopmental toxicity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  G L Kimmel,et al.  Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  Robert Kavlock,et al.  Mode of Action: Inhibition of Androgen Receptor Function—Vinclozolin-Induced Malformations in Reproductive Development , 2005, Critical reviews in toxicology.

[40]  M. Höfler,et al.  Causal inference based on counterfactuals , 2005, BMC medical research methodology.

[41]  John M DeSesso,et al.  Mode of Action: Yolk Sac Poisoning and Impeded Histiotrophic Nutrition—HBOC-Related Congenital Malformations , 2005, Critical reviews in toxicology.

[42]  D. Weed Environmental epidemiology: basics and proof of cause-effect. , 2002, Toxicology.

[43]  Harvey Clewell,et al.  Use of mode of action in risk assessment: past, present, and future. , 2005, Regulatory toxicology and pharmacology : RTP.

[44]  P M Schlosser,et al.  Determining modes of action for biologically based risk assessments. , 1999, Regulatory toxicology and pharmacology : RTP.

[45]  J. Goodman The traditional toxicologic paradigm is correct: dose influences mechanism. , 1998, Environmental health perspectives.

[46]  Gary M Williams,et al.  DNA-Reactive Carcinogens: Mode of Action and Human Cancer Hazard , 2005, Critical reviews in toxicology.

[47]  Trevor Green,et al.  Case study: weight of evidence evaluation of the human health relevance of thiamethoxam-related mouse liver tumors. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  J. Bucher,et al.  Evaluating the human relevance of chemically induced animal tumors. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  G C Becking Use of mechanistic information in risk assessment for toxic chemicals. , 1995, Toxicology letters.

[50]  D. Weed Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[51]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[52]  G. Daston Advances in understanding mechanisms of toxicity and implications for risk assessment. , 1997, Reproductive toxicology.

[53]  Hugh A. Barton,et al.  Assessing Susceptibility from Early-Life Exposure to Carcinogens , 2005, Environmental health perspectives.